Structure-based design of peptidomimetic ligands of the Grb2-SH2 domain

被引：23

作者：

Schoepfer, J ^{[1
]}

Gay, B ^{[1
]}

Caravatti, G ^{[1
]}

Garcia-Echeverria, C ^{[1
]}

Fretz, H ^{[1
]}

Rahuel, J ^{[1
]}

Furet, P ^{[1
]}

机构：

[1] Novartis Pharma Inc, Oncol Res Dept, CH-4002 Basel, Switzerland

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1998年 / 8卷 / 20期

关键词：

D O I：

10.1016/S0960-894X(98)00513-7

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We have designed and synthesized a (3-aminomethyl-phenyl)-urea scaffold to mimic the X+1-Asn part of the minimal phosphopeptide sequence, Ac-pTyr-X+1-Asn-NH2, recognized by the Grb2-SH2 domain. The resulting compounds show the same degree of affinity as their peptide counterparts for the Grb2-SH2 domain. This is the first example reported to date of ligands of the Grb2-SH2 domain with substantially reduced peptidic character. (C) 1998 Elsevier Science Ltd. All rights reserved.

引用

页码：2865 / 2870

页数：6

共 50 条

[1] Structure-based design of peptidomimetics ligands that bind to the Grb2-SH2 domain.
Schoepfer, J
Gay, B
Caravatti, G
Garcia-Echeverria, C
Fretz, H
Rahuel, J
Furet, P
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U282 - U282
[2] Structure-based design and synthesis of nigh affinity tripeptide ligands of the Grb2-SH2 domain
Furet, P
Gay, B
Caravatti, G
García-Echeverría, C
Rahuel, J
Schoepfer, J
Fretz, H
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) : 3442 - 3449
[3] Structure-based design of potent Grb2-SH2 domain antagonists not relying on phosphotyrosine mimics
Jiang, Sheng
Li, Peng
Peach, Megan L.
Bindu, Lakshman
Worthy, Karen W.
Fisher, Robert J.
Burke, Terrence R., Jr.
Nicklaus, Marc
Roller, Peter P.
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 349 (02) : 497 - 503
[4] Structure-based design of thioether-bridged cyclic phosphopeptides binding to Grb2-SH2 domain
Li, P
Peach, ML
Zhang, MC
Liu, HP
Yang, DJ
Nicklaus, M
Roller, PP
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (05) : 895 - 899
[5] Peptidomimetic design of cyclic Grb2-SH2 domain antagonists not relying on pTyr or its mimics
Roller, Peter P.
Li, Peng
Zhang, Manchao
Zhang, Xiaodong
Long, Ya-Qiu
Peach, Megan L.
Nicklaus, Marc
Liu, Hongpeng
Yang, Dajun
[J]. PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, 2004, : 501 - 503
[6] Peptidomimetic design of cyclic Grb2-SH2 domain antagonists not relying on pTyr or its mimics.
Roller, PP
Li, P
Zhang, M
Long, YQ
Peach, ML
Nicklaus, M
Liu, H
Yang, D
[J]. BIOPOLYMERS, 2003, 71 (03) : 384 - 384
[7] Structure-based design and synthesis of phosphinate isosteres of phosphotyrosine for incorporation in Grb2-SH2 domain inhibitors.: Part 1
Furet, P
Caravatti, G
Denholm, AA
Faessler, A
Fretz, H
García-Echeverría, C
Gay, B
Irving, E
Press, NJ
Rahuel, J
Schoepfer, J
Walker, CV
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (20) : 2337 - 2341
[8] DESIGN OF NEW GRB2-SH2 DOMAIN INHIBITORS BASED ON A PHARMACOPHORE MODEL
Olivella, Mireia
Rodriguez Torrecillas, Ivan
Pardo, Leonardo
Campillo, Mercedes
[J]. DRUGS OF THE FUTURE, 2009, 34 : 211 - 211
[9] Structure-based design and synthesis of thioether-bridged cyclic peptides as highly potent Grb2-SH2 domain inhibitors.
Li, P
Li, BH
Zhang, MC
Yang, DJ
Roller, PP
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U47 - U47
[10] Fusion protein based on Grb2-SH2 domain for cancer therapy
Saito, Yuriko
Furukawa, Takako
Arano, Yasushi
Fujibayashi, Yasuhisa
Saga, Tsuneo
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 399 (02) : 262 - 267

← 1 2 3 4 5 →